06/16/21 5:19 PMNYSE : PFEData Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 PneumoniaPfizer Inc. (NYSE: PFE) and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein today announced that the New England Journal of Medicine has published positive findings from the STOP-COVID study (NCT04469114) evaluating the efficacy and safety of oral Janus kinaseRHEA-AIneutral
06/16/21 10:00 AMNYSE : PFEPfizer Invites Public to View and Listen to Webcast of Pfizer July 28 Conference Call with AnalystsPfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Wednesday, July 28, 2021. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s SecondRHEA-AIneutral
06/10/21 2:00 AMNYSE, Nasdaq : PFE, BNTXPfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest NationsPfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200 million doses in 2021 and 300 million doses in the first half of 2022, to further support the multilateralRHEA-AIneutral
06/08/21 7:12 PMNYSE : PFEU.S. FDA Approves PREVNAR 20™, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or OlderPfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved PREVNAR 20 ™ (Pneumococcal 20-valent Conjugate Vaccine) for the prevention of invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae (pneumococcus) serotypes in the vaccine inRHEA-AIneutral
05/24/21 6:45 AMNYSE : PFEPfizer Initiates Study Exploring Coadministration of Its 20-valent Pneumococcal Conjugate Vaccine Candidate Along With a Third Dose of the Pfizer-BioNTech COVID-19 Vaccine in Older AdultsPfizer Inc. (NYSE: PFE) today announced that the first enrolled subjects have received their immunizations as part of a new study in adults ages 65 or older exploring the coadministration of the company’s 20-valent pneumococcal conjugate vaccine (20vPnC) candidate following a booster dose of theRHEA-AIneutral
05/20/21 5:00 AMNYSE, Nasdaq : PFE, BNTXPfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY®Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY ®, the companies’ COVID-19 vaccine, to the European Union (EU), with an option for the EC to request up to an additional 900 millionRHEA-AInegative
05/10/21 9:02 PMNYSE, Nasdaq : PFE, BNTXPfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in AdolescentsPfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for their COVID-19 vaccine to include individuals 12 to 15 years of age. This is the first COVID-19 vaccine authorized in theRHEA-AIneutral
05/07/21 6:45 AMNYSE, Nasdaq : PFE, BNTXPfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of Their COVID-19 VaccinePfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older. Data to support the BLARHEA-AIneutral
05/06/21 6:30 AMNYSE, Nasdaq : PFE, BNTXPfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo GamesPfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a Memorandum of Understanding (MoU) with the International Olympic Committee (IOC) to donate doses of the companies’ COVID-19 Vaccine to help vaccinate athletes, and their delegations, participating in the OlympicRHEA-AInegative
05/04/21 6:45 AMNYSE : PFEPFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTSPfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2021 and raised 2021 guidance (3) for revenues and Adjusted diluted EPS (2) driven by the updated expectations for contributions to 2021 performance from BNT162b2, the Pfizer-BioNTech SE (BioNTech) COVID-19 vaccine, as well as theRHEA-AIneutral
